-
Purposeexpression of plasma membrane signal from Lyn11 fused to CIBN and tagged with GFP
-
Depositing Labs
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 79572 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEGFP-N1
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameLyn11
-
Alt name11 N-terminal amino acid residues of Lyn kinase
-
SpeciesH. sapiens (human)
-
MutationG8R (please see depositor comments below)
- Promoter CMV
-
Tags
/ Fusion Proteins
- CIBN (CRY2-binding domain) (C terminal on backbone)
- EGFP (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site AgeI (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer EGFP-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
CIBN was fused N-terminally to GFP in pEGFP-N1 using Nhe1/Age1. Complementary oligonucleotides encoding Lyn11 with flanking Nhe1-sites subsequently were annealed and ligated N-terminally to CIBN. Lipidation for plasma membrane attachment occurs at amino acids 2 and 3. The G8R mutations stabilise the protein at the plasma membrane.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Lyn11-CIBN-GFP was a gift from Pietro De Camilli & Olof Idevall-Hagren (Addgene plasmid # 79572 ; http://n2t.net/addgene:79572 ; RRID:Addgene_79572) -
For your References section:
Optogenetic control of phosphoinositide metabolism. Idevall-Hagren O, Dickson EJ, Hille B, Toomre DK, De Camilli P. Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2316-23. doi: 10.1073/pnas.1211305109. Epub 2012 Jul 30. 10.1073/pnas.1211305109 PubMed 22847441